Kees de Ruig

Business Development Manager

Bilateral Meetings

  • Thursday (1:30pm – 6:00pm)
  • Friday (9:00am – 12:00pm)
DescriptionTranslational medicine is the transformation of laboratory research outcomes into new ways to diagnose and treat patients to improve the health of millions of people worldwide. It takes promising biomedical innovations 'from bench to bedside' and bridges clinical needs from bedside to bench. EATRIS provides a new development pathway, open to researchers and companies in need of support for advancing biomedical innovations. EATRIS comprises over 70 leading academic institutions across Europe, each renowned for its individual and high-end research facilities. This infrastructure provides the following advantages:
  • Single point of access to the right expertise and facilities
  • Expedites the development process
  • Access to large and diverse clinical patient cohorts
Organization Type Cluster
Organization Size11-25
CityAmsterdam,, De Boelelaan 1118 Google map

Cutting edge infrastructure and expertise along the entire translational value chain

The EATRIS consortium of academic institutes provides cutting edge infrastructure and expertise along the entire translational value chain. Benefit from our ‘One-Stop Shop’ access to reach first-in-human application and on to clinical proof-of-concept in our five interrelated, highly specialized product areas.

With top quality facilities for basic research, manufacture, non-clinical and clinical development, our EATRIS institutes offer a truly multidisciplinary environment including patient cohorts and key opinion leader interaction. Take advantage of a comprehensive infrastructure for the following product classes:

Advanced Therapy Medicinal Products (ATMP)
Imaging and Tracing
Small Molecules

Cooperation Offered
  1. Technical co-operation
  2. Outsourcing co-operation

European network of expert partners to provide essential input to your translational strategy

In addition, EATRIS C&S provides access to a European network of expert partners, available to provide essential input to your translational strategy. They offer advice and capacity for:

Translational review of project including confirmation of unmet medical need, clear end product envisaged, innovative character and IP clarity (link to core process/access EATRIS).
Identifying the optimal regulatory strategy during translational development including performance of EMA Scientific Advice preparation & follow-up, clinical trial document preparation, application procedure handling and deadline monitoring via the EATRIS Regulatory and knowledge centres.
Input of clinical specialists into your development programme.
Access to large and diverse patient groups.

Cooperation Offered
  1. Outsourcing co-operation
  2. Technical co-operation